Status:
COMPLETED
Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Thyroid Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study is being done to understand the decision-making process regarding management choice in low-risk papillary thyroid cancer.
Eligibility Criteria
Inclusion
- Able to read, write, and communicate in English Patients who have been diagnosed with LR-PTC as described above
- For Aim 1, adults with recently diagnosed LR-PTC who have not yet made a choice between surgery and AS
- For Aim 2, adults with LR-PTC who made a decision about surgery or AS at least 3 months prior, but no more than 4 years prior to their routine follow-up visit at which they are being recruited for this study.
- Active patients of MSK and participating institutions
Exclusion
- Patients who have been diagnosed with a tumor greater than 2 cm
- Patients with clinically suspicious lymphadenopathy in the neck
- Patients with evidence of gross ETE after a biopsy of the papillary thyroid tumor
Key Trial Info
Start Date :
August 7 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 13 2023
Estimated Enrollment :
186 Patients enrolled
Trial Details
Trial ID
NCT03300284
Start Date
August 7 2017
End Date
July 13 2023
Last Update
July 21 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Hartford Healthcare (Data Collection)
Hartford, Connecticut, United States, 06102
2
Memorial Sloan Kettering Monmouth (Consent and Follow up)
Middletown, New Jersey, United States, 07748
3
MAIMONIDES MEDICAL CENTER (Data collection only)
Brooklyn, New York, United States, 11220
4
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065